Respiratory Training for Heart Failure
(RETRO Trial)
Trial Summary
What is the purpose of this trial?
In a randomized controlled trial, to study the utility of inspiratory muscle training (IMT) to improve functional outcomes in adults aged β₯70 years with heart failure (HF) who have been referred to palliative care for end-stage HF management. * The study team hypothesize that older HF patients will be able to use IMT safely, reliably, and effectively in a 12-week home-based training regimen. * The study team hypothesize that physical function (sit to stand, gait speed, grip strength), respiratory/pulmonary function, self-efficacy, fatigue and quality of life will increase among older HF patients randomized IMT versus those randomized to usual care.
Will I have to stop taking my current medications?
The trial protocol does not specify whether you need to stop taking your current medications. However, it mentions that participants should be on optimal therapy according to heart failure guidelines, which suggests you may need to continue your current heart failure treatment.
What data supports the effectiveness of the treatment Inspiratory Muscle Training (IMT) for heart failure?
Is inspiratory muscle training (IMT) safe for humans?
How is the treatment Inspiratory Muscle Training (IMT) different from other treatments for heart failure?
Inspiratory Muscle Training (IMT) is unique because it specifically targets and strengthens the muscles used for breathing, which can improve respiratory muscle strength and endurance. Unlike other heart failure treatments that may focus on medication or lifestyle changes, IMT is a physical training method that can enhance breathing capacity and potentially improve quality of life for patients with heart failure.24568
Research Team
Daniel Forman, MD
Principal Investigator
University of Pittsburgh
Eligibility Criteria
This trial is for adults aged 70 or older with heart failure who are receiving palliative care for end-stage management of their condition. Participants should be able to perform a home-based training regimen.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants undergo a 12-week home-based Inspiratory Muscle Training (IMT) program
Follow-up
Participants are monitored for safety and effectiveness after treatment
Treatment Details
Interventions
- Inspiratory Muscle Training (IMT)
Inspiratory Muscle Training (IMT) is already approved in European Union, United States, Canada for the following indications:
- Heart Failure
- Chronic Obstructive Pulmonary Disease (COPD)
- Respiratory Muscle Weakness
- Heart Failure
- Respiratory Muscle Weakness
- Pulmonary Rehabilitation
- Heart Failure
- Chronic Obstructive Pulmonary Disease (COPD)
- Respiratory Muscle Weakness
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Pittsburgh
Lead Sponsor
The Pittsburgh Foundation
Collaborator